WebDisclosure WebDisclosure
Basculer en Français
11310 Companies
251337 Keywords
180414 Articles
137158 Press releases
Headlines Articles Press releases Transcend Clinic Remove
  1. Home
  2. Companies
  3. Transcend Clinic
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/01/2024 at 17:05, 2 years 1 month ago

    Transcend Clinic Announces the Opening of New Treatment Clinic on October 1st

    Addiction Recovery Ibogaine Treatment Holistic Therapy Medical Supervision Long-term Support
  • BRIEF

    published on 10/01/2024 at 17:05, 2 years 1 month ago

    La clinique Transcend annonce l'ouverture d'une nouvelle clinique de traitement le 1er octobre

    Traitement À L'ibogaïne Guérison De La Dépendance Thérapie Holistique Surveillance Médicale Un Soutien À Long Terme
  • PRESS RELEASE

    published on 10/01/2024 at 17:00, 2 years 1 month ago

    Transcend Clinic Announces the Opening of New Treatment Clinic on October 1st

    Transcend Clinic announces the opening of its new clinic dedicated to offering ibogaine-assisted addiction treatment with a focus on long-term recovery and holistic care
    Recovery Addiction Transcend Clinic Ibogaine-assisted Treatment Holistic Care
    Logo of Transcend Clinic
Accesswire
  • Published on 11/10/2026 at 14:45, 21 minutes ago

    An Investigational Drug to Tackle Measles Outbreaks

  • Published on 11/10/2026 at 14:31, 35 minutes ago

    First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms

  • Published on 11/10/2026 at 14:30, 36 minutes ago

    Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer

  • Published on 11/10/2026 at 14:30, 36 minutes ago

    ACCESS Newswire Reports Third Quarter 2026 Results

  • Published on 11/10/2026 at 14:00, 1 hour 6 minutes ago

    Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL

View all ACCESSWIRE
EQS Group
  • Published on 11/10/2026 at 14:55, 11 minutes ago

    Geely Farizon Launches 2027 Model Year SV in Germany, Bringing Integrated Passenger and Commercial Vehicle Services to Local Customers

  • Published on 11/10/2026 at 14:49, 17 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 11/10/2026 at 14:48, 18 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

  • Published on 11/10/2026 at 14:47, 19 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: SEGRO plc

  • Published on 11/10/2026 at 14:46, 20 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc

View all EQS
Les Echos
  • Published on 11/10/2026 at 14:00, 1 hour 6 minutes ago

    Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 2 au 6 novembre 2026

  • Published on 11/10/2026 at 14:00, 1 hour 6 minutes ago

    Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026

  • Published on 11/10/2026 at 11:02, 4 hours 3 minutes ago

    Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026

  • Published on 11/10/2026 at 11:02, 4 hours 3 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026

  • Published on 11/10/2026 at 07:00, 8 hours 6 minutes ago

    bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy